pharma-and-clinical-pharmacy-congress-2016_tracks

11 / 21

Notes:
Page 39
Pharma & Clinical Pharmacy Congress 2016
November 07-09, 2016
Volume 5 Issue 4(Suppl) Clin Pharmacol Biopharm
ISSN: 2167-065X CPB, an open access journal
conferenceseries .com
November 07-09, 2016 Las Vegas, Nevada, USA
4th International
Pharma & Clinical Pharmacy Congress
Stefan Bughi et al., Clin Pharmacol Biopharm 2016, 5:4(Suppl)
Addressing inpatient polypharmacy: A multidisciplinary team intervention to improve patient
safety
Stefan Bughi, Ashley Manchanda, Stephanie A Bughi, Richard Wong, Fernando Gonzalez, Shan-Pin Fanchiang, Brian Joyo, Bryan Kakehashi, Almara Nazarian,
Andrew Wong and Sylvia Shaw
Rancho Los Amigos National Rehabilitation Center, USA
Background: Polypharmacy (PPRx) is common among US patient population, and may be as high as 50% in patients over 65.
PPRx among inpatients can be associated with an increased rate of medical errors, adverse reactions, prolong hospitalization
and cost.
Aim: The goals of the present project were to explore the prevalence of PPRx at our facility and raise awareness and provide
guidance regarding reduction of PPRx.
Methods: Using electronic medical record we reviewed the medication list for the inpatients admitted at our facility in the
spring of 2016. PPRx was defined as taking more than 10 drugs. Hospitalists were informed about the risks and possible
consequences of PPRx and modalities to correct them. Interventions via multidisciplinary team work, safety rounds and
improve communication in addressing PPRx were implemented, as part of a quality/safety improvement project.
Results: Among the 105 inpatients, 87 (83%) experienced PPRx, taking an average of 15.6 medications. The average patient age
was 48.7±10.7 years, 78/87 (90%) were male and 9/87 (10%) were female. These patients received a total of 1353 medications, of
which 56% were scheduled medications (SM) and 44% were PRN meds. Among many patients with PPRx: H2 Blockers/PPI’s
were prescribed without a clinical diagnosis; Benadryl was frequently used as a PRN sleep medication; and muscle relaxant
and narcotics were frequently prescribed concomitantly. The project outcome reflected in the April 2016 data, which compared
with the data from April 2015 showed an 80% decrease of prescribed multiple sedating agents.
Conclusion: Successful interventions to decrease polypharmacy requiremultidisciplinary teamwork, educational interventions
and increase communication.
Biography
Stefan Bughi is a Clinical Associate Professor of Medicine at the Keck School of Medicine, University of Southern California in Los Angeles in the Division of
Diabetes/Endocrinology. He is board certified in Internal Medicine and Endocrinology and presently working as a Physician Specialist at Rancho Los Amigos
National Rehabilitation Center (RLANRC). He is the Chair of Graduate Medical Education, the Chair of the Physician Well-Being Committee and the Physician
Patient Safety Officer at RLANRC. He is also a Member of the Medication Safety Committee. He is a Fellow of the American Board of Diabetes and Fellow of the
American Institute of Stress. He has completed his Master’s in Academic Medicine from USC Keck School of Medicine. His research interests include human factor
and patient safety, endocrinology of stress and the effects of stress on psychosomatic disorders and stress and medical profession. He has presented his research
data at local, national and international meetings.